WO2012009828A1 - Chemical modification method and detection method of 5-hydroxymethylcytosine in dna molecules - Google Patents

Chemical modification method and detection method of 5-hydroxymethylcytosine in dna molecules Download PDF

Info

Publication number
WO2012009828A1
WO2012009828A1 PCT/CN2010/001107 CN2010001107W WO2012009828A1 WO 2012009828 A1 WO2012009828 A1 WO 2012009828A1 CN 2010001107 W CN2010001107 W CN 2010001107W WO 2012009828 A1 WO2012009828 A1 WO 2012009828A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
hydroxymethylcytosine
minutes
amplified
pcr
Prior art date
Application number
PCT/CN2010/001107
Other languages
French (fr)
Chinese (zh)
Inventor
邓大君
陆哲明
周静
Original Assignee
北京市肿瘤防治研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京市肿瘤防治研究所 filed Critical 北京市肿瘤防治研究所
Priority to PCT/CN2010/001107 priority Critical patent/WO2012009828A1/en
Publication of WO2012009828A1 publication Critical patent/WO2012009828A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates

Definitions

  • the present invention belongs to the field of epigenetics research, and in particular to a method for chemically modifying 5-hydroxymethylcytosine in a DNA molecule, and detecting 5-hydroxymethylcytosine or 5-hydroxymethyl group present in a DNA molecule.
  • DNA cytosine methylation, histone modification, non-coding R A is an important epigenetic mechanism that regulates gene expression and plays an important role in normal cell differentiation, embryonic development, and disease development.
  • the 5-methylation modification of DNA cytosine was the most stable. In adult vertebrate cell DNA, methylation of this DNA cytosine occurs only at the CpG site. There are many regions in the genomic DNA in which CpG sites are highly dense, and one of the sequences longer than 250 bp is called a CpG island.
  • the state of methylation of the CpG island located around the initiation point (TSS) of the gene plays a crucial role in determining the transcriptionality of the gene: the region near the TSS site is reproducible when it is unmethylated, Those who develop methylation are inactivated because they cannot be transcribed.
  • TSS initiation point
  • This methylation information can be stably maintained for a long time in various tissue samples and can be sensitively detected.
  • 5-methylcytosine can be further oxidized to 5-hydroxymethylcytosine by enzymatic catalysis such as TET1.
  • enzymatic catalysis such as TET1.
  • chromatography or mass spectrometry separation techniques 5-hydroxymethylcytosine has been found in embryonic stem cells and certain brain stem tissue cells.
  • chromatographic or mass spectrometry separation techniques can only be used to determine the presence of 5-hydroxymethylcytosine in the DNA of the assay sample, and the specific location of 5-hydroxymethylcytosine in the DNA sequence cannot be determined. Since the various DNA-sequence-specific 5-methylcytosine assays currently used do not distinguish 5-hydroxymethylcytosine from 5-methylcytosine, the location of 5-hydroxymethylcytosine Research on biological functions and their relationship with disease development is difficult to carry out.
  • the invention of a technique suitable for DNA sequence-specific 5-hydroxymethylcytosine analysis is expected by the international epigenetic basis and applied research field.
  • the currently used 5-hydroxymethylcytosine assay is a chromatographic total analysis method that analyzes DNA after digestion into nucleosides or single nucleotides. It does not provide information on which sites of cytosine in the DNA are hydroxyl. Methylation information.
  • the currently used DNA sequence-specific 5-methylcytosine analysis technique is not suitable for the analysis of 5-hydroxymethylcytosine.
  • the existing sodium bisulfite chemical modification method cannot convert 5-hydroxymethylcytosine into uracil, and cannot distinguish it from 5-methylcytosine; 5-methylcytosine monoclonal antibody, N-methylation-sensitive enzymes and methylated DNA-binding proteins do not recognize 5-hydroxymethylcytosine and cannot be distinguished from unmethylated cytosine. That is, chromatin co-precipitation using a 5-hydroxymethylcytosine-specific antibody did not identify the specific position of 5-hydroxymethylcytosine in the precipitated DNA sequence.
  • the object of the present invention is to provide a method for chemically modifying 5-hydroxymethylcytosine in a DNA molecule, and a method for detecting a 5-hydroxymethylcytosine or a 5-hydroxymethylcytosine site present in a DNA molecule
  • the present invention is based on the fact that the applicant has found that the 5-hydroxymethylcytosine in the DNA has been modified in the existing chemical modification method of sodium hydrogen sulfite, and the 5-hydroxymethylcytosine is converted after modification.
  • the transformation product is used as a PCR amplification template.
  • dTTP is used in the PCR system, it is amplified to thymine T or if dUTP is used in the PCR system, it is amplified into uracil U.
  • the invention provides a chemical modification method of 5-hydroxymethylcytosine in a DNA molecule, the method comprising the following steps: treating the DNA with sodium bisulfite chemical modification method to make 5-hydroxyl group present in the DNA
  • the cytosine is transformed and the transformed product is used as a template for PCR amplification and amplified into thymine T or uracil U in conventional PCR.
  • the method for chemically modifying 5-hydroxymethylcytosine in the DNA molecule of the present invention wherein the treatment of the DNA by the chemical modification method of sodium hydrogen sulfite is one of the following methods:
  • Aqueous sodium hydroxide solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L of sodium hydrogen sulfite, followed by 95.
  • C 5 minutes, 60 ° C, 25 minutes, 95 ° C, 5 minutes, 60 ° (:, 85 minutes, 95 ° C, 5 minutes, 60 ° C, 175 minutes, heat cycle DNA treatment, plus final concentration 0.3 Mol/L sodium hydroxide terminates the sulfonation reaction and desulfurization, purifies the modified DNA, precipitates with ethanol, and dissolves;
  • Using the Methylation-God kit: ZYMO Research China, Cat. No. D5005 or the present invention provides a method for detecting a 5-hydroxymethylcytosine site present in a DNA molecule, the method comprising the steps of:
  • a piece of DNA is treated with sodium bisulfite chemical modification method to convert 5-hydroxymethylcytosine present in the DNA, and the transformation product can be used as a template for PCR amplification and amplified in conventional PCR.
  • Another identical DNA is treated by sodium bisulfite chemical modification method, so that the 5-hydroxymethylcytosine present in the DNA is not transformed, and is amplified into cytosine C in conventional PCR;
  • Step D is to digest the amplified two DNAs by restriction endonuclease, if step A is expanded The amplified DNA product is not digested, and the DNA product amplified in step B is digested or if the DNA product amplified in step A is cleaved, and the DNA product amplified in step B is not digested. Then, a 5-hydroxymethylcytosine site is present on the restriction endonuclease recognition site in the DNA molecule.
  • the method for detecting a 5-hydroxymethylcytosine site present in a DNA molecule according to the present invention wherein the treatment of the DNA by the sodium hydrogen sulfite chemical modification method in the step A is one of the following methods :
  • Aqueous sodium hydroxide solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L of sodium hydrogen sulfite, followed by 95. C, 5 minutes, 60. C, 25 minutes, 95. C, 5 minutes, 60° (, 85 minutes, 95° (:, 5 minutes, 60. (, 175 minutes, heat cycle treatment of DNA, addition of final concentration of 0.3mol/L sodium hydroxide to terminate the sulfonation reaction and desulfurization, purification Modified DNA, ethanol precipitation, dissolution; or
  • a method for detecting a 5-hydroxymethylcytosine site present in DNA according to the present invention characterized N2010/001107
  • Step B The sodium bisulphite chemical modification method is used to treat the DNA: adding 0.1 mol/L sodium hydroxide aqueous solution to the DNA sample solution, 95 ° C water bath for 5 minutes, adding the final concentration 5 mol/L of sodium hydrogen sulfite, 55 ° C water bath for 16 hours, adding a final concentration of 0.3 mol / L sodium hydroxide to terminate the sulfonation reaction and desulfurization, purification of the modified DNA, ethanol precipitation, dissolution.
  • the present invention provides a method for detecting the presence of 5-hydroxymethylcytosine in a DNA molecule, the method comprising the steps of:
  • a piece of DNA is treated with sodium bisulfite chemical modification method to convert hydroxymethylcytosine present in the DNA, and the transformed product is used as a template for PCR amplification and amplified into thymine T in conventional PCR. Or uracil U;
  • Another identical DNA is treated by sodium bisulfite chemical modification method, so that the 5-hydroxymethylcytosine present in the DNA is not transformed, and is amplified into cytosine C in conventional PCR;
  • the denaturing temperature of the DNA molecule was predicted by denaturing high performance liquid chromatography workstation software, and the PCR product was subjected to mutation mode analysis by denaturing high performance liquid chromatography under the temperature condition;
  • step E After PCR amplification of the DNA treated in step A, the PCR product appears as a single-stranded DNA chromatographic peak, and the DNA processed in step B is PCR-amplified and the PCR product appears as a double-stranded DNA peak, and the DNA molecule is determined. There is 5-hydroxymethylcytosine.
  • the method for detecting 5-hydroxymethylcytosine present in a DNA molecule according to the present invention wherein the treatment of the DNA by sodium bisulfite chemical modification as described in the step A is as follows:
  • Aqueous sodium hydroxide solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L of sodium hydrogen sulfite, followed by 95. C, 5 minutes, 60 ° C, 25 minutes, 95. C, 5 minutes, 60° ( , 85 minutes, 95 ° C, 5 minutes, 60 ° C, 175 minutes, heat cycle DNA treatment, add final concentration 0.3mol / L sodium hydroxide to terminate the sulfonation reaction and desulfurization, purification modification After DNA, ethanol precipitation, dissolution; or
  • the method for detecting 5-hydroxymethylcytosine present in DNA according to the present invention is characterized in that: in step B, the DNA is treated by sodium bisulfite chemical modification method: 0.1 mol is added to the DNA sample solution /L aqueous sodium hydroxide solution, 95 ° C water bath for 5 minutes, adding a final concentration of 5 mol / L
  • the sodium hydrogen sulfite was subjected to a water bath at 55 ° C for 16 hours, and the sulfonation reaction and desulfurization were terminated by adding a final concentration of 0.3 mol/L sodium hydroxide, and the modified DNA was purified, precipitated by ethanol, and dissolved.
  • the invention also provides the use of sodium bisulfite for modifying or detecting the presence of 5-hydroxymethylcytosine in a DNA molecule.
  • the use according to the present invention is characterized in that: the sodium hydrogen sulfite modification converts 5-hydroxymethylcytosine present in the DNA molecule, and the transformed product is used as a template for PCR amplification and is amplified in conventional PCR. Thymine T or uracil U.
  • the sodium hydrogen sulfite is an EpiTect Bisulfite kit containing sodium bisulfite: Qiagen GmbH, D40724 Hilden, Cat. No. 59104 or Methylation-God kit: ZYMO Research China, Cat. No. D5005 or D5006.
  • the method of the present invention can conveniently detect the presence of 5-hydroxymethylcytosine or its site in the DNA sequence of interest, providing a powerful tool for epigenetic research.
  • experimental methods, experimental reagents, experimental materials and the like used in the present invention are all conventional experimental methods, experimental reagents, and experimental materials well known to those skilled in the art unless otherwise specified.
  • Figure 1 is a schematic illustration of the invention.
  • Figure 2 is a HPLC analysis of the presence of various single nucleotides in synthetic H-DNA, M-DNA and C-DNA molecules.
  • Figure 3A and Figure 3B are DHPLC chromatograms of six PCR amplification products of three DNA templates modified by Method A and Method B.
  • Figure 4 shows the Ncol fragment length polymorphism of the six PCR products. The best way to implement the invention
  • method A sodium bisulphite chemical modification method is used to convert 5-hydroxymethylcytosine H in DNA, and the conversion product is S.
  • Method B the sodium bisulfite chemical modification method does not modify the 5-hydroxymethylcytosine H in the DNA to be S, but ⁇ '; in the subsequent PCR amplification reaction, S is amplified to thymidine (eg Substituting dUTP for dTTP in the PCR system is uracil U), and H' without modification to S is amplified.
  • cytosine C if 5-C cytosine M is replaced by 5C-dCTP instead of dCTP in PCR system); 5-methylcytosine will not be modified by these two methods, and will be modified in subsequent PCR amplification reactions. Amplification to cytosine; cytosine without 5-methylation or 5-hydroxymethylation modification is modified by these two methods to form uracil, which is amplified into thymidine in subsequent PCR amplification reactions.
  • the sequence C/T or C/U differential site in the PCR products of these two chemically modified templates is the 5-hydroxymethylcytosine presence site.
  • H-DNA, M-DNA and C-DNA samples taken 2 ⁇ g of purified H-DNA, M-DNA and C-DNA samples, digest and digest into single nucleotides, and isolate them by HPLC: H-DNA, M-DNA and C-DNA Only hm-dCMP, 5m-dCMP and dCMP were detected in the digested products; dTMP, dGMP and dAMP were detected in all three DNA digestion products, see Figure 2;
  • a 0.1 mol/L sodium hydroxide aqueous solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L sodium hydrogen sulfite, 95. (:, 5 min, 60 ° C, 25 min, 95. (:, 5 min, 60. (, 85 min, 95. (:, 5 min, 60 ° C, 175 min, heat cycle DNA treatment, purification modification)
  • the final concentration of 0.3 mol / L sodium hydroxide was terminated by sulfonation and desulfurization, and the modified DNA was purified by Promega kit (Cat. No. A7280) and precipitated with ethanol;
  • the modified DNA (Cat. No. A7280) was purified by ethanol precipitation, dissolved in deionized water or TE buffer after drying;
  • primer pair 2 forward primer: SEQ ID No.: 4 and reverse primer: SEQ ID No.: 5
  • three kinds of DNA templates modified by the above method A and method B were amplified, respectively, to obtain C. - PCR2A, C-PCR2B, M-PCR2A.
  • H-PCR2B six products, identified by agarose gel electrophoresis;
  • step 7 Replace the method A in step 3 with one of the following methods, and the result is the same as step 7.
  • H-PCR2A All H sites in the PCR amplification product (H-PCR2A) of the H-DNA template modified by Method A were replaced by T, and the PCR amplification product of the H-DNA template modified by Method B (H- Most of the H sites in PCR2B) are not replaced by T and still be expressed as C; and 2 amplifications of methylated DNA All M sites in the product are expressed as C, and all C sites in the two amplification products of unmethylated DNA exhibit T;
  • T is expressed in Method A, and the site represented as C in Method B is the site where 5-hydroxymethylation occurs.
  • step 8 Replace the method A in step 3 with one of the following methods, and the result is the same as step 8.
  • Both M-PCR2A and M-PCR2B molecules retained the cleavage point of the enzyme, and were completely digested into two fragments of 251 bp and 142 bp by the enzyme; all H-PCR2A did not have the enzyme cleavage point and could not be digested; part of H-PCR2B retained The enzyme cleavage site is digested by the enzyme;
  • the amplification products of the two modification methods were completely digested, and the cytosine of the two cleavage sites was methylated; the amplification products of the two modification methods were not digested by the enzyme.
  • the cytosine is not methylated; the amplification product of the modification method A is not digested, and the amplification product of the modification method B is digested by the enzyme digestor or the amplification product of the modification method A, and the modification method B is expanded. If the product is not cleaved, the cytosine has been methylolated.
  • step 8 Replace the method A in step 3 with one of the following methods, and the result is the same as step 8.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a method for chemically modifying 5-hydroxymethylcytosine in DNA molecules by sodium bisulfite, and a method for detecting the presence of 5-hydroxymethylcytosine or the locus of 5-hydroxymethylcytosine existing in DNA molecules. The invention also provides a use of sodium bisulfite for modifying or detecting 5-hydroxymethylcytosine existing in DNA molecules.

Description

DNA分子中 5-羟甲基胞嘧啶的化学修饰方法及检测方法 技术领域  Chemical modification method and detection method of 5-hydroxymethylcytosine in DNA molecule
本发明属于表观遗传学研究领域, 具体地, 涉及一种 DNA分子中 5-羟 甲基胞嘧啶的化学修饰方法, 检测 DNA分子中存在的 5-羟甲基胞嘧啶或 5- 羟甲基胞嘧啶位点的方法及亚硫酸氢钠用于修饰 DNA分子中存在的 5-羟甲 基胞嘧啶的用途。 背景技术  The present invention belongs to the field of epigenetics research, and in particular to a method for chemically modifying 5-hydroxymethylcytosine in a DNA molecule, and detecting 5-hydroxymethylcytosine or 5-hydroxymethyl group present in a DNA molecule. A method of cytosine site and the use of sodium bisulfite for modifying 5-hydroxymethylcytosine present in a DNA molecule. Background technique
DNA胞嘧啶甲基化、 组蛋白修饰、 非编码 R A是调控基因表达的三种 重要的表观遗传(epigenetic)机制, 在正常细胞的分化、 胚胎发育和疾病发 生过程中发挥重要作用。 在这三种表观遗传机制中, 以 DNA胞嘧啶的 5-甲 基化修饰变化最为稳定。在成年的脊椎动物细胞 DNA中,这种 DNA胞嘧啶 的甲基化只发生在 CpG位点上。在基因组 DNA中存在许多 CpG位点高度密 集的区域,其中的一种长度大于 250bp的序列被称为 CpG岛。位于基因转录 启始点(TSS)周围的 CpG岛甲基化的状态在决定该基因的可转录性上发挥 着至关重要的作用: TSS位点附近区域保持未甲基化时具有可转录性, 而发 生甲基化者则因不能转录而失活。 CpG岛甲基化与肿瘤等细胞分化异常疾病 发生和发展之间存在密切的关系, 这种甲基化信息在各种组织标本中能够长 期稳定保持,并且能够被灵敏地检测。这些不仅使得 CpG岛甲基化分析成为 基因表达调控研究的重要手段, 而且在肿瘤等疾病的发生和发展及新药开发 上有重要的应用价值。 DNA cytosine methylation, histone modification, non-coding R A is an important epigenetic mechanism that regulates gene expression and plays an important role in normal cell differentiation, embryonic development, and disease development. Among the three epigenetic mechanisms, the 5-methylation modification of DNA cytosine was the most stable. In adult vertebrate cell DNA, methylation of this DNA cytosine occurs only at the CpG site. There are many regions in the genomic DNA in which CpG sites are highly dense, and one of the sequences longer than 250 bp is called a CpG island. The state of methylation of the CpG island located around the initiation point (TSS) of the gene plays a crucial role in determining the transcriptionality of the gene: the region near the TSS site is reproducible when it is unmethylated, Those who develop methylation are inactivated because they cannot be transcribed. There is a close relationship between CpG island methylation and the occurrence and development of abnormal cell differentiation diseases such as tumors. This methylation information can be stably maintained for a long time in various tissue samples and can be sensitively detected. These not only make CpG island methylation analysis an important means of gene expression regulation research, but also have important application value in the occurrence and development of tumors and other diseases and new drug development.
5-甲基胞嘧啶(5-methylcytosine) 可在 TET1 等酶促催化下进一步氧化 成 5-羟甲基胞嘧啶 (5-hydroxymethylcytosine)。 利用色谱或质谱分离鉴定技 术, 人们已经发现胚胎干细胞和某些脑干组织细胞中存在 5-羟甲基胞嘧啶。 然而, 利用色谱或质谱分离鉴定技术只能了解测定样品 DNA中是否存在 5- 羟甲基胞嘧啶, 无法确定 5-羟甲基胞嘧啶在 DNA序列中的具体位置。 由于 目前所使用的各种 DNA-序列特异性 5-甲基胞嘧啶分析方法无法将 5-羟甲基 胞嘧啶与 5-甲基胞嘧啶区分, 所以对 5-羟甲基胞嘧啶的存在位置、 生物学功 能及其与疾病发生发展关系的研究均难以开展。有报道 TET1酶基因与 MLL 基因异常异位融合是白血病细胞中的常见现象, 暗示 5-羟甲基胞嘧啶发生异 常在疾病的发生发展上可能发挥重要的作用。 发明一种能够适合 DNA序列 特异性 5-羟甲基胞嘧啶分析的技术正为国际表观遗传基础和应用研究领域的 人们所期待。 目前所使用的 5-羟甲基胞嘧啶测定技术是在将 DNA消化成核苷或单核 苷酸后再进行分析的色谱总量分析方法, 无法提供 DNA中哪些位点的胞嘧 啶发生了羟甲基化的信息。 而目前常用的 DNA序列特异性 5-甲基胞嘧啶分 析技术不适合于 5-羟甲基胞嘧啶的分析。 例如, 现有亚硫酸氢钠化学修饰法 不能将 5-羟甲基胞嘧啶转化脱氨基成尿嘧啶,不能将之与 5-甲基胞嘧啶相区 分; 5-甲基胞嘧啶单克隆抗体、 甲基化敏感酶、 甲基化 DNA结合蛋白均不能 识别 5-羟甲基胞嘧啶, 无法将之与未甲基化的胞嘧啶相区分。 即使用 5-羟甲 基胞嘧啶特异性抗体进行染色质共沉淀, 也无法标识出沉淀的 DNA序列中 5-羟甲基胞嘧啶的具体位置。 5-methylcytosine can be further oxidized to 5-hydroxymethylcytosine by enzymatic catalysis such as TET1. Using chromatography or mass spectrometry separation techniques, 5-hydroxymethylcytosine has been found in embryonic stem cells and certain brain stem tissue cells. However, chromatographic or mass spectrometry separation techniques can only be used to determine the presence of 5-hydroxymethylcytosine in the DNA of the assay sample, and the specific location of 5-hydroxymethylcytosine in the DNA sequence cannot be determined. Since the various DNA-sequence-specific 5-methylcytosine assays currently used do not distinguish 5-hydroxymethylcytosine from 5-methylcytosine, the location of 5-hydroxymethylcytosine Research on biological functions and their relationship with disease development is difficult to carry out. Abnormal ectopic fusion of the TET1 enzyme gene with the MLL gene has been reported to be a common phenomenon in leukemia cells, suggesting that abnormalities in 5-hydroxymethylcytosine may play an important role in the development of the disease. The invention of a technique suitable for DNA sequence-specific 5-hydroxymethylcytosine analysis is expected by the international epigenetic basis and applied research field. The currently used 5-hydroxymethylcytosine assay is a chromatographic total analysis method that analyzes DNA after digestion into nucleosides or single nucleotides. It does not provide information on which sites of cytosine in the DNA are hydroxyl. Methylation information. The currently used DNA sequence-specific 5-methylcytosine analysis technique is not suitable for the analysis of 5-hydroxymethylcytosine. For example, the existing sodium bisulfite chemical modification method cannot convert 5-hydroxymethylcytosine into uracil, and cannot distinguish it from 5-methylcytosine; 5-methylcytosine monoclonal antibody, N-methylation-sensitive enzymes and methylated DNA-binding proteins do not recognize 5-hydroxymethylcytosine and cannot be distinguished from unmethylated cytosine. That is, chromatin co-precipitation using a 5-hydroxymethylcytosine-specific antibody did not identify the specific position of 5-hydroxymethylcytosine in the precipitated DNA sequence.
因此, 目前需要一种可以便利地检测 DNA分子中是否存在 5-羟甲基胞 嘧的方法, 及检测 DNA分子中 5-羟甲基胞嘧位点的方法。 发明的公开  Therefore, there is a need for a method for conveniently detecting the presence or absence of 5-hydroxymethylcytosine in a DNA molecule, and a method for detecting a 5-hydroxymethylcytosolic site in a DNA molecule. Disclosure of invention
本发明的目的是提供一种 DNA分子中 5-羟甲基胞嘧啶的化学修饰方法, 检测 DNA分子中存在的 5-羟甲基胞嘧啶或 5-羟甲基胞嘧啶位点的方法及亚 硫酸氢钠用于修饰 DNA分子中存在的 5-羟甲基胞嘧啶的用途。  The object of the present invention is to provide a method for chemically modifying 5-hydroxymethylcytosine in a DNA molecule, and a method for detecting a 5-hydroxymethylcytosine or a 5-hydroxymethylcytosine site present in a DNA molecule The use of sodium bisulfate for modifying 5-hydroxymethylcytosine present in DNA molecules.
本发明是基于申请人发现现有的亚硫酸氢钠化学修饰法中 DNA中的 5- 羟甲基胞嘧啶有被修饰的事实, 并且修饰后该 5-羟甲基胞嘧啶会发生转化, 该转化产物作为 PCR扩增模板,在常规 PCR中,如果 PCR体系中使用 dTTP, 则被扩增为胸腺嘧啶 T或如果 PCR体系中使用 dUTP, 则扩增为尿嘧啶 U。  The present invention is based on the fact that the applicant has found that the 5-hydroxymethylcytosine in the DNA has been modified in the existing chemical modification method of sodium hydrogen sulfite, and the 5-hydroxymethylcytosine is converted after modification. The transformation product is used as a PCR amplification template. In conventional PCR, if dTTP is used in the PCR system, it is amplified to thymine T or if dUTP is used in the PCR system, it is amplified into uracil U.
由此本发明提出了如下技术方案:  Therefore, the present invention proposes the following technical solutions:
本发明提供了一种 DNA分子中 5-羟甲基胞嘧啶的化学修饰方法, 该方 法包括下列步骤: 用亚硫酸氢钠化学修饰法对该 DNA进行处理,使 DNA中 存在的 5-羟甲基胞嘧啶发生转化,转化产物作为 PCR扩增模板,在常规 PCR 中被扩增为胸腺嘧啶 T或尿嘧啶 U。  The invention provides a chemical modification method of 5-hydroxymethylcytosine in a DNA molecule, the method comprising the following steps: treating the DNA with sodium bisulfite chemical modification method to make 5-hydroxyl group present in the DNA The cytosine is transformed and the transformed product is used as a template for PCR amplification and amplified into thymine T or uracil U in conventional PCR.
本发明所述的 DNA分子中 5-羟甲基胞嘧啶的化学修饰方法, 其中所述 用亚硫酸氢钠化学修饰法对该 DNA进行处理是如下之一所列的方法:  The method for chemically modifying 5-hydroxymethylcytosine in the DNA molecule of the present invention, wherein the treatment of the DNA by the chemical modification method of sodium hydrogen sulfite is one of the following methods:
A1. 向 DNA样品溶液中加入氢氧化钠水溶液, 95°C水浴 5分钟, 加入终 浓度 5mol/L的亚硫酸氢钠,然后 95。C、 5分钟, 60°C、 25分钟, 95°C、 5分, 60° (:、 85分钟, 95。C、 5分钟, 60°C、 175分钟, 热循环处理 DNA, 加终浓度 0.3mol/L氢氧化钠终止磺酸化反应和脱硫, 纯化修 饰后的 DNA, 乙醇沉淀, 溶解; 或者 A1. Aqueous sodium hydroxide solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L of sodium hydrogen sulfite, followed by 95. C, 5 minutes, 60 ° C, 25 minutes, 95 ° C, 5 minutes, 60 ° (:, 85 minutes, 95 ° C, 5 minutes, 60 ° C, 175 minutes, heat cycle DNA treatment, plus final concentration 0.3 Mol/L sodium hydroxide terminates the sulfonation reaction and desulfurization, purifies the modified DNA, precipitates with ethanol, and dissolves;
A2. 向 DNA样品溶液中加入终浓度 9mol/L 的亚硫酸氢钠, 70°C水浴 1 小时, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者  A2. Add a final concentration of 9mol/L sodium bisulfite to the DNA sample solution, and hydrate the modified DNA for 1 hour at 70 °C to precipitate and dissolve the ethanol; or
A3.用 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No. 59104; 或者 A3. Use EpiTect Bisulfite kit: Qiagen GmbH, D40724 Hilden, Cat. No. 59104; or
A4.用 Methylation-God试剂盒: ZYMO Research中国, Cat. No. D5005或 本发明提供了一种检测 DNA分子中存在的 5-羟甲基胞嘧啶位点的方法, 该方法包括以下步骤:  A4. Using the Methylation-God kit: ZYMO Research China, Cat. No. D5005 or the present invention provides a method for detecting a 5-hydroxymethylcytosine site present in a DNA molecule, the method comprising the steps of:
A.用亚硫酸氢钠化学修饰法对一份 DNA进行处理, 使 DNA中存在的 5- 羟甲基胞嘧啶发生转化, 该转化产物能够作为 PCR扩增模板, 在常规 PCR中被扩增为胸腺嘧啶 T或尿嘧啶 U;  A. A piece of DNA is treated with sodium bisulfite chemical modification method to convert 5-hydroxymethylcytosine present in the DNA, and the transformation product can be used as a template for PCR amplification and amplified in conventional PCR. Thymine T or uracil U;
B.用亚硫酸氢钠化学修饰法对另一份相同的 DNA进行处理, 使 DNA中 存在的 5-羟甲基胞嘧啶不发生转化,在常规 PCR中被扩增为胞嘧啶 C; B. Another identical DNA is treated by sodium bisulfite chemical modification method, so that the 5-hydroxymethylcytosine present in the DNA is not transformed, and is amplified into cytosine C in conventional PCR;
C.以所述两份经过处理的 DNA为模板,用序列特异性引物分别扩增所述 DNA分子; C. using the two treated DNAs as a template, and respectively amplifying the DNA molecules with sequence-specific primers;
D.对扩增后的两份 DNA分别测序,比对测序后 DNA中的 C/T或 C/U差 别位点, 该 C/T或 C U差别位点即是 DNA分子中存在的 5-羟甲基胞 嘧啶位点。  D. Sequencing the amplified two DNAs separately, comparing the C/T or C/U differential sites in the DNA after sequencing, the C/T or CU differential sites are the 5-hydroxyl groups present in the DNA molecule. Methylcytosine site.
本发明所述的检测 DNA分子中存在的 5-羟甲基胞嘧啶位点的方法, 其 特征在于: 步骤 D是用限制性内切酶酶切扩增后的两份 DNA, 如果步骤 A 扩增后的 DNA产物未被酶切,而步骤 B扩增后的 DNA产物被酶切或者如果 步骤 A扩增后的 DNA产物被酶切,而步骤 B扩增后的 DNA产物未被酶切, 则 DNA分子中酶切识别位点上存在 5-羟甲基胞嘧啶位点。  The method for detecting a 5-hydroxymethylcytosine site present in a DNA molecule according to the present invention is characterized in that: Step D is to digest the amplified two DNAs by restriction endonuclease, if step A is expanded The amplified DNA product is not digested, and the DNA product amplified in step B is digested or if the DNA product amplified in step A is cleaved, and the DNA product amplified in step B is not digested. Then, a 5-hydroxymethylcytosine site is present on the restriction endonuclease recognition site in the DNA molecule.
本发明所述的检测 DNA分子中存在的 5-羟甲基胞嘧啶位点的方法, 其 中步骤 A中所述用亚硫酸氢钠化学修饰法对该 DNA进行处理是如下之一所 列的方法:  The method for detecting a 5-hydroxymethylcytosine site present in a DNA molecule according to the present invention, wherein the treatment of the DNA by the sodium hydrogen sulfite chemical modification method in the step A is one of the following methods :
A1. 向 DNA样品溶液中加入氢氧化钠水溶液, 95°C水浴 5分钟, 加入终 浓度 5mol/L的亚硫酸氢钠,然后 95。C、 5分钟, 60。C、 25分钟, 95。C、 5分, 60° (、 85分钟, 95° (:、 5分钟, 60。 (、 175分钟, 热循环处理 DNA, 加终浓度 0.3mol/L氢氧化钠终止磺酸化反应和脱硫, 纯化修 饰后的 DNA, 乙醇沉淀, 溶解; 或者  A1. Aqueous sodium hydroxide solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L of sodium hydrogen sulfite, followed by 95. C, 5 minutes, 60. C, 25 minutes, 95. C, 5 minutes, 60° (, 85 minutes, 95° (:, 5 minutes, 60. (, 175 minutes, heat cycle treatment of DNA, addition of final concentration of 0.3mol/L sodium hydroxide to terminate the sulfonation reaction and desulfurization, purification Modified DNA, ethanol precipitation, dissolution; or
A2. 向 DNA样品溶液中加入终浓度 9mol/L 的亚硫酸氢钠, 70°C水浴 1 小时, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者  A2. Add a final concentration of 9mol/L sodium bisulfite to the DNA sample solution, and hydrate the modified DNA for 1 hour at 70 °C to precipitate and dissolve the ethanol; or
A3. 用 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No.  A3. Using EpiTect Bisulfite Kit: Qiagen GmbH, D40724 Hilden, Cat. No.
59104; 或者  59104; or
A4.用 Methylation-God试剂盒: ZYMO Research中国, Cat. No. D5005或 D5006。  A4. Use Methylation-God kit: ZYMO Research China, Cat. No. D5005 or D5006.
本发明所述的检测 DNA中存在的 5-羟甲基胞嘧啶位点的方法, 其特征 N2010/001107 A method for detecting a 5-hydroxymethylcytosine site present in DNA according to the present invention, characterized N2010/001107
-4- 在于:步骤 B中用亚硫酸氢钠化学修饰法对该 DNA迸行处理是: 向 DNA样 品溶液中加入 0.1mol/L的氢氧化钠水溶液, 95°C水浴 5分钟, 加入终浓度 5 mol/L的亚硫酸氢钠, 55°C水浴 16小时, 加终浓度 0.3 mol/L氢氧化钠终止 磺酸化反应和脱硫, 纯化修饰后的 DNA, 乙醇沉淀, 溶解。  -4- lie in: Step B: The sodium bisulphite chemical modification method is used to treat the DNA: adding 0.1 mol/L sodium hydroxide aqueous solution to the DNA sample solution, 95 ° C water bath for 5 minutes, adding the final concentration 5 mol/L of sodium hydrogen sulfite, 55 ° C water bath for 16 hours, adding a final concentration of 0.3 mol / L sodium hydroxide to terminate the sulfonation reaction and desulfurization, purification of the modified DNA, ethanol precipitation, dissolution.
本发明提供一种检测 DNA分子中存在 5-羟甲基胞嘧啶的方法, 该方法 包括以下步骤:  The present invention provides a method for detecting the presence of 5-hydroxymethylcytosine in a DNA molecule, the method comprising the steps of:
A.用亚硫酸氢钠化学修饰法对一份 DNA进行处理, 使 DNA中存在的羟 甲基胞嘧啶发生转化, 该转化产物作为 PCR扩增模板, 在常规 PCR 中被扩增为胸腺嘧啶 T或尿嘧啶 U;  A. A piece of DNA is treated with sodium bisulfite chemical modification method to convert hydroxymethylcytosine present in the DNA, and the transformed product is used as a template for PCR amplification and amplified into thymine T in conventional PCR. Or uracil U;
B.用亚硫酸氢钠化学修饰法对另一份相同的 DNA进行处理, 使 DNA中 存在的 5-羟甲基胞嘧啶不发生转化,在常规 PCR中被扩增为胞嘧啶 C; B. Another identical DNA is treated by sodium bisulfite chemical modification method, so that the 5-hydroxymethylcytosine present in the DNA is not transformed, and is amplified into cytosine C in conventional PCR;
C.以所述两份经过处理的 DNA为模板,用序列特异性引物分别扩增所述 DNA分子, 得到 PCR产物; C. using the two treated DNAs as a template, and respectively amplifying the DNA molecules with sequence-specific primers to obtain a PCR product;
D.用变性高效液相色谱工作站软件预测 DNA分子变性温度,在该温度条 件下用变性高效液相色谱对 PCR产物进行突变模式分析;  D. The denaturing temperature of the DNA molecule was predicted by denaturing high performance liquid chromatography workstation software, and the PCR product was subjected to mutation mode analysis by denaturing high performance liquid chromatography under the temperature condition;
E.步骤 A所处理的 DNA经过 PCR扩增后 PCR产物表现为单链 DNA色 谱峰,并且步骤 B所处理的 DNA经过 PCR扩增后 PCR产物表现为双 链 DNA色谱峰, 则确定该 DNA分子存在 5-羟甲基胞嘧啶。  E. After PCR amplification of the DNA treated in step A, the PCR product appears as a single-stranded DNA chromatographic peak, and the DNA processed in step B is PCR-amplified and the PCR product appears as a double-stranded DNA peak, and the DNA molecule is determined. There is 5-hydroxymethylcytosine.
本发明所述的检测 DNA分子中存在的 5-羟甲基胞嘧啶的方法, 其中步 骤 A中所述用亚硫酸氢钠化学修饰法对该 DNA进行处理是如下之一所列的 方法:  The method for detecting 5-hydroxymethylcytosine present in a DNA molecule according to the present invention, wherein the treatment of the DNA by sodium bisulfite chemical modification as described in the step A is as follows:
A1. 向 DNA样品溶液中加入氢氧化钠水溶液, 95°C水浴 5分钟, 加入终 浓度 5mol/L的亚硫酸氢钠,然后 95。C、 5分钟, 60°C、 25分钟, 95。C、 5分, 60° ( 、 85分钟, 95。C、 5分钟, 60°C、 175分钟, 热循环处理 DNA, 加终浓度 0.3mol/L氢氧化钠终止磺酸化反应和脱硫, 纯化修 饰后的 DNA, 乙醇沉淀, 溶解; 或者  A1. Aqueous sodium hydroxide solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L of sodium hydrogen sulfite, followed by 95. C, 5 minutes, 60 ° C, 25 minutes, 95. C, 5 minutes, 60° ( , 85 minutes, 95 ° C, 5 minutes, 60 ° C, 175 minutes, heat cycle DNA treatment, add final concentration 0.3mol / L sodium hydroxide to terminate the sulfonation reaction and desulfurization, purification modification After DNA, ethanol precipitation, dissolution; or
A2. 向 DNA样品溶液中加入终浓度 9mol/L的亚硫酸氢钠, 70°C水浴 1 小时, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者  A2. Add a final concentration of 9 mol/L sodium bisulfite to the DNA sample solution, and heat the modified DNA for 1 hour at 70 ° C to precipitate and dissolve the ethanol; or
A3.用 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No.  A3. Using EpiTect Bisulfite Kit: Qiagen GmbH, D40724 Hilden, Cat. No.
59104; 或者  59104; or
A4.用 Methylation-God试剂盒: ZYMO Research中国, Cat. No. D5005或 D5006。  A4. Use Methylation-God kit: ZYMO Research China, Cat. No. D5005 or D5006.
本发明所述的检测 DNA中存在的 5-羟甲基胞嘧啶的方法,其特征在于: 步骤 B中用亚硫酸氢钠化学修饰法对该 DNA进行处理是:向 DNA样品溶液 中加入 0.1mol/L的氢氧化钠水溶液, 95°C水浴 5分钟, 加入终浓度 5 mol/L 的亚硫酸氢钠, 55°C水浴 16小时, 加终浓度 0.3 mol/L氢氧化钠终止磺酸化 反应和脱硫, 纯化修饰后的 DNA, 乙醇沉淀, 溶解。 The method for detecting 5-hydroxymethylcytosine present in DNA according to the present invention is characterized in that: in step B, the DNA is treated by sodium bisulfite chemical modification method: 0.1 mol is added to the DNA sample solution /L aqueous sodium hydroxide solution, 95 ° C water bath for 5 minutes, adding a final concentration of 5 mol / L The sodium hydrogen sulfite was subjected to a water bath at 55 ° C for 16 hours, and the sulfonation reaction and desulfurization were terminated by adding a final concentration of 0.3 mol/L sodium hydroxide, and the modified DNA was purified, precipitated by ethanol, and dissolved.
本发明也提供了亚硫酸氢钠用于修饰或检测 DNA分子中存在的 5-羟甲 基胞嘧啶的用途。  The invention also provides the use of sodium bisulfite for modifying or detecting the presence of 5-hydroxymethylcytosine in a DNA molecule.
本发明所述的用途, 其特征在于: 所述亚硫酸氢钠修饰使 DNA分子中 存在的 5-羟甲基胞嘧啶发生转化,转化产物作为 PCR扩增模板,在常规 PCR 中被扩增为胸腺嘧啶 T或尿嘧啶 U。  The use according to the present invention is characterized in that: the sodium hydrogen sulfite modification converts 5-hydroxymethylcytosine present in the DNA molecule, and the transformed product is used as a template for PCR amplification and is amplified in conventional PCR. Thymine T or uracil U.
本发明所述的用途, 其特征在于: 所述的亚硫酸氢钠是含有亚硫酸氢钠 的 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No. 59104或 者 Methylation-God试剂盒: ZYMO Research中国, Cat. No. D5005或 D5006。  The use according to the invention is characterized in that: the sodium hydrogen sulfite is an EpiTect Bisulfite kit containing sodium bisulfite: Qiagen GmbH, D40724 Hilden, Cat. No. 59104 or Methylation-God kit: ZYMO Research China, Cat. No. D5005 or D5006.
本发明的方法可以便利地检测出目的 DNA序列中存在的 5-羟甲基胞嘧 啶或其位点, 为表观遗传学的研究提供了有力的工具。  The method of the present invention can conveniently detect the presence of 5-hydroxymethylcytosine or its site in the DNA sequence of interest, providing a powerful tool for epigenetic research.
为了更好地理解本发明, 现在结合附图及具体实施方式对本发明进行 详细的说明。 需要说明的是, 所述的实施例仅仅是示例本发明的目的, 而 不应该理解为对本发明的任何限制。  The invention will now be described in detail with reference to the drawings and specific embodiments. It is to be understood that the examples are merely illustrative of the invention and should not be construed as limiting the invention.
另外本发明中所使用的实验方法、 实验试剂、 实验材料等如无特别说 明均为本领域普通技术人员所熟知的常规的实验方法、 实验试剂、 实验材 料。 附图的简要说明  Further, the experimental methods, experimental reagents, experimental materials and the like used in the present invention are all conventional experimental methods, experimental reagents, and experimental materials well known to those skilled in the art unless otherwise specified. BRIEF DESCRIPTION OF THE DRAWINGS
图 1是本发明原理图示。  BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a schematic illustration of the invention.
图 2是 HPLC法分析人工合成的 H-DNA、 M-DNA和 C-DNA分子中各 种单核苷酸的存在情况。 色谱柱: Supelcosil C-128 ; 流动相: 0.1%甲酸铵 +0~100%甲醇线性梯度; 紫外检测器 260nm。  Figure 2 is a HPLC analysis of the presence of various single nucleotides in synthetic H-DNA, M-DNA and C-DNA molecules. Column: Supelcosil C-128; Mobile phase: 0.1% ammonium formate + 0~100% methanol linear gradient; UV detector 260 nm.
图 3A和图 3B是经方法 A和方法 B修饰的 3种 DNA模板的 6种 PCR 扩增产物 DHPLC色谱图。  Figure 3A and Figure 3B are DHPLC chromatograms of six PCR amplification products of three DNA templates modified by Method A and Method B.
图 4是六种 PCR产物的 Ncol酶切片段长度多态性。 实现本发明的最佳方式  Figure 4 shows the Ncol fragment length polymorphism of the six PCR products. The best way to implement the invention
参考图 1, 是本发明的原理的示意图:  Referring to Figure 1, there is shown a schematic diagram of the principles of the present invention:
利用 2种亚硫酸氢钠化学修饰技术(分别称为方法 A和方法 B), 在方 法 A中亚硫酸氢钠化学修饰法将 DNA中的 5-羟甲基胞嘧啶 H转化,转化产 物为 S, 在方法 B中亚硫酸氢钠化学修饰法不修饰 DNA中的 5-羟甲基胞嘧 啶 H为 S, 而是 Η'; 在后继 PCR扩增反应中 S被扩增为胸腺嘧啶 Τ (如用 dUTP代替 PCR体系中的 dTTP则为尿嘧啶 U), 未修饰为 S的 H'则被扩增 为胞嘧啶 C (如用 5m-dCTP代替 PCR体系中的 dCTP则为 5-甲基胞嘧啶 M); 5-甲基胞嘧啶不会被这 2种方法修饰,在后继 PCR扩增反应中被扩增为胞嘧 啶;未发生 5-甲基化或 5-羟甲基化修饰的胞嘧啶则被这 2种方法修饰形成尿 嘧啶, 在后继 PCR扩增反应中被扩增为胸腺嘧啶丁。这 2种化学修饰模板的 PCR产物中序列 C/T或 C/U差别位点即为 5-羟甲基胞嘧啶存在位点。 Using two kinds of sodium bisulfite chemical modification techniques (referred to as method A and method B, respectively), in the method A, sodium bisulphite chemical modification method is used to convert 5-hydroxymethylcytosine H in DNA, and the conversion product is S. In Method B, the sodium bisulfite chemical modification method does not modify the 5-hydroxymethylcytosine H in the DNA to be S, but Η'; in the subsequent PCR amplification reaction, S is amplified to thymidine (eg Substituting dUTP for dTTP in the PCR system is uracil U), and H' without modification to S is amplified. It is cytosine C (if 5-C cytosine M is replaced by 5C-dCTP instead of dCTP in PCR system); 5-methylcytosine will not be modified by these two methods, and will be modified in subsequent PCR amplification reactions. Amplification to cytosine; cytosine without 5-methylation or 5-hydroxymethylation modification is modified by these two methods to form uracil, which is amplified into thymidine in subsequent PCR amplification reactions. The sequence C/T or C/U differential site in the PCR products of these two chemically modified templates is the 5-hydroxymethylcytosine presence site.
显然, 如何使用亚硫酸氢钠化学修饰法对 DNA进行修饰属于本领域己 知的技术, 本发明只是发现了亚硫酸氢钠化学修饰法的新应用。 实施例 1  Obviously, how to modify DNA using sodium bisulfite chemical modification is a well-known technique in the art, and the present invention has only found a new application of the chemical modification method of sodium hydrogen sulfite. Example 1
1. 直接用含 dCTP的 dNTP和扩增引物对 1 (正向引物: SEQ ID No.: l和反 向引物: SEQ ID No.: 2), PCR法合成所有 C位点均为未甲基化和未羟甲基 化的代表性 DNA分子 (C-DNA) (SEQ ID No.:3 );  1. Directly use dCTP-containing dNTPs and amplification primer pair 1 (forward primer: SEQ ID No.: l and reverse primer: SEQ ID No.: 2), and all C sites are unmethylated by PCR. Representative and non-hydroxymethylated representative DNA molecules (C-DNA) (SEQ ID No.: 3);
用 hm-dCTP替代 PCR扩增体系中的 dCTP,用扩增引物对 1 (正向引物: SEQ ID No.: 1和反向引物: SEQ ID No.: 2), PCR法合成所有 C位点均被 H 替换的代表性羟甲基胞嘧啶的 DNA分子(H-DNA);  Replace dCTP in the PCR amplification system with hm-dCTP, and synthesize all C sites by amplification primer pair 1 (forward primer: SEQ ID No.: 1 and reverse primer: SEQ ID No.: 2). a DNA molecule (H-DNA) of a representative hydroxymethylcytosine that is replaced by H;
用 5m-dCTP替代 PCR扩增体系中的 dCTP,用扩增引物对 1 (正向引物: SEQ ID No.: 1和反向引物: SEQ ID No.: 2), PCR法合成所有 C位点均被 M 替换的代表性 DNA分子 (M-DNA);  Replacing dCTP in the PCR amplification system with 5m-dCTP, and synthesizing all C sites by amplification primer pair 1 (forward primer: SEQ ID No.: 1 and reverse primer: SEQ ID No.: 2) Representative DNA molecules (M-DNA) each replaced by M;
2. 去除游离 dNTP; 取 2微克纯化的 H-DNA、 M-DNA和 C-DNA样品, 分 别酶切消化成单核苷酸, HPLC分离鉴定合格: H-DNA、 M-DNA和 C-DNA 的消化产物中分别仅检测到 hm-dCMP、 5m-dCMP和 dCMP; dTMP、 dGMP、 dAMP则在 3种 DNA消化产物中均可检出, 见图 2;  2. Remove free dNTPs; take 2 μg of purified H-DNA, M-DNA and C-DNA samples, digest and digest into single nucleotides, and isolate them by HPLC: H-DNA, M-DNA and C-DNA Only hm-dCMP, 5m-dCMP and dCMP were detected in the digested products; dTMP, dGMP and dAMP were detected in all three DNA digestion products, see Figure 2;
3.取上述纯化过的 3种 DNA各 2微克,使用下列 A方法,分别处理 3种 DNA 样品:  3. Take 2 μg of each of the above purified DNAs and treat the three DNA samples separately using the following A method:
向 DNA样品溶液中加入 0.1 mol/L的氢氧化钠水溶液, 95°C水浴 5分钟, 加入 5 mol/L终浓度的亚硫酸氢钠, 95。 (:、 5分钟, 60°C、 25分钟, 95。 (:、 5 分钟, 60。 (、 85分钟, 95。 (:、 5分钟, 60°C、 175分钟, 热循环处理 DNA, 纯化修饰后的 DNA, 加终浓度 0.3 mol/L 氢氧化钠终止磺酸化反应 (sulfonation)和脱硫, 用 Promega试剂盒(Cat. No. A7280) 纯化修饰后的 DNA, 乙醇沉淀;  A 0.1 mol/L sodium hydroxide aqueous solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L sodium hydrogen sulfite, 95. (:, 5 min, 60 ° C, 25 min, 95. (:, 5 min, 60. (, 85 min, 95. (:, 5 min, 60 ° C, 175 min, heat cycle DNA treatment, purification modification) After the DNA, the final concentration of 0.3 mol / L sodium hydroxide was terminated by sulfonation and desulfurization, and the modified DNA was purified by Promega kit (Cat. No. A7280) and precipitated with ethanol;
4. 同样取上述纯化过的 3种 DNA各 2微克, 使用下述 B方法, 分别处理 3 种 DNA样品:  4. Take 2 micrograms of each of the above purified DNAs, and use the following B method to treat 3 DNA samples separately:
向 DNA样品溶液中加入 0.1 mol/L的氢氧化钠水溶液, 95°C水浴 5分钟, 加入终浓度 5 mol/L 的亚硫酸氢钠, 55°C水浴 16小时, 促使 C脱氨基, 加 终浓度 0.3 mol/L氢氧化钠终止磺酸化反应(sulfonation)和脱硫,用 Promega 试剂盒(Cat. No. A7280)纯化修饰后的 DNA, 乙醇沉淀, 千燥后溶解于去离 子水或者 TE缓冲液中; Add 0.1 mol/L sodium hydroxide aqueous solution to the DNA sample solution, water bath at 95 ° C for 5 minutes, add 5 mol / L sodium bisulfite at a final concentration, and bath at 55 ° C for 16 hours to promote C deamination and add Termination of sulfonation and desulfurization with a concentration of 0.3 mol/L sodium hydroxide, with Promega The modified DNA (Cat. No. A7280) was purified by ethanol precipitation, dissolved in deionized water or TE buffer after drying;
5.用引物对 2 (正向引物: SEQ ID No.: 4和反向引物: SEQ ID No.: 5 ) 分别 扩增用上述方法 A和方法 B修饰过的 3种 DNA模板, 分别获得 C-PCR2A、 C-PCR2B、 M-PCR2A. M-PCR2B、 H-PCR2A. H-PCR2B六种产物, 琼脂胶 电泳鉴定;  5. Using primer pair 2 (forward primer: SEQ ID No.: 4 and reverse primer: SEQ ID No.: 5), respectively, three kinds of DNA templates modified by the above method A and method B were amplified, respectively, to obtain C. - PCR2A, C-PCR2B, M-PCR2A. M-PCR2B, H-PCR2A. H-PCR2B six products, identified by agarose gel electrophoresis;
6.用变性高效液相色谱 (DHPLC) 工作站软件 (WaveMaker或 Navigator) 预测待测 DNA片段 PCR产物的部分变性温度(53.5°C), 在该温度条件下用 DHPLC (DNASep®分析柱)对步骤 5所或 6种 PCR产物进行突变模式分析。 结果见: 羟甲基化 DNA的 2种扩增产物分别表现为单链 DNA和双链 DNA 色谱峰, 而甲基化 DNA的 2种扩增产物均表现双链 DNA色谱峰, 非甲基化 DNA的 2种扩增产物则均表现单链 DNA色谱峰(图 3A和图 3B):  6. Determinate the partial denaturation temperature (53.5 °C) of the PCR product of the DNA fragment to be tested by denaturing high performance liquid chromatography (DHPLC) workstation software (WaveMaker or Navigator), and use DHPLC (DNASep® analytical column) to perform the step at this temperature. Five or six PCR products were subjected to mutation pattern analysis. The results are as follows: The two amplification products of methylolated DNA are single-stranded DNA and double-stranded DNA peaks, while the two amplified products of methylated DNA exhibit double-stranded DNA peaks, unmethylated. Both amplification products of DNA showed single-stranded DNA peaks (Fig. 3A and Fig. 3B):
[1]在 C-PCR2A和 C-PCR2B产物中,只能在 4.2分钟检测到由于发生了非甲 基化的 C" T替换, 变性温度低的单链的 DNA色谱峰;  [1] In the C-PCR2A and C-PCR2B products, a single-stranded DNA peak having a low denaturation temperature due to the occurrence of non-methylated C"T substitution was detected only at 4.2 minutes;
[2]在 M-PCR2A和 M-PCR2B产物中, 只能在 5.5分钟检测到由于甲基化的 C未发生替换, 变性温度较高的双链的 DNA色谱峰;  [2] In the M-PCR2A and M-PCR2B products, double-stranded DNA peaks with high denaturation temperature were detected only in 5.5 minutes due to methylation of C;
[3]在 H-PCR2A产物中,只能在 4.2分钟检测到由于发生了羟甲基化的 C T 替换,变性温度低的单链的 DNA色谱峰;而在 H-PCR2B产物中,只能在 5.5 分钟检测到由于羟甲基化的 C未发生替换, 变性温度较高的双链的 DNA色 谱峰;  [3] In the H-PCR2A product, a single-stranded DNA peak with a low denaturation temperature due to CT substitution of methylolation was detected only at 4.2 minutes; whereas in the H-PCR2B product, only The DNA peak of the double-stranded DNA with higher denaturation temperature was detected in 5.5 minutes due to no substitution of methylolated C;
7. 结果判断: 在方法 A中表现为单链 DNA色谱峰, 并且在方法 B中表现为 双链 DNA色谱峰的产物存在 DNA羟甲基化。  7. Judgment of results: A single-stranded DNA peak is shown in Method A, and DNA methylation is present in the product of Method B as a double-stranded DNA peak.
用下列方法之一代替步骤 3中的 A方法, 结果同步骤 7。  Replace the method A in step 3 with one of the following methods, and the result is the same as step 7.
A2. 向 DNA样品溶液中加入终浓度 9 mol/L的亚硫酸氢钠, 70°C水浴 1 小时, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者  A2. Add a final concentration of 9 mol/L sodium bisulfite to the DNA sample solution, and heat the modified DNA for 1 hour at 70 ° C to precipitate and dissolve the ethanol; or
A3.用 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No.  A3. Using EpiTect Bisulfite Kit: Qiagen GmbH, D40724 Hilden, Cat. No.
59104; 或者  59104; or
A4. 用 Methylation-God试剂盒: ZYMO Research中国, Cat No. D5005 或 D5006o  A4. Using Methylation-God Kit: ZYMO Research China, Cat No. D5005 or D5006o
实施例 2 Example 2
1-5. 同实施例 1步骤 1-5  1-5. Same as Embodiment 1 Step 1-5
6.将新鲜扩增的 6种 PCR2产物分别连接到 AT克隆上, 进行测序;  6. Six freshly amplified PCR2 products were ligated to AT clones for sequencing;
7.经方法 A修饰的 H-DNA模板的 PCR扩增产物 (H-PCR2A) 中的所有 H 位点均被 T取代,而经方法 B修饰的 H-DNA模板的 PCR扩增产物 ( H-PCR2B ) 中的大部分 H位点未被 T取代, 仍然表现为 C; 而甲基化 DNA的 2种扩增 产物中的所有 M位点均表现为 C, 非甲基化 DNA的 2种扩增产物中的所有 C位点均则表现 T; 7. All H sites in the PCR amplification product (H-PCR2A) of the H-DNA template modified by Method A were replaced by T, and the PCR amplification product of the H-DNA template modified by Method B (H- Most of the H sites in PCR2B) are not replaced by T and still be expressed as C; and 2 amplifications of methylated DNA All M sites in the product are expressed as C, and all C sites in the two amplification products of unmethylated DNA exhibit T;
8. 结果判断:在方法 A中表现为 T,并且在方法 B中表现为 C的位点为发生 5-羟甲基化的位点。  8. Judgment of results: T is expressed in Method A, and the site represented as C in Method B is the site where 5-hydroxymethylation occurs.
用下列方法之一代替步骤 3中的 A方法, 结果同步骤 8。  Replace the method A in step 3 with one of the following methods, and the result is the same as step 8.
A2. 向 DNA样品溶液中加入终浓度 9 mol/L 的亚硫酸氢钠, 70。C水浴 A2. Add a final concentration of 9 mol/L sodium bisulfite, 70 to the DNA sample solution. C water bath
1小时, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者 1 hour, purification of the modified DNA, ethanol precipitation, dissolution; or
A3.用 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No.  A3. Using EpiTect Bisulfite Kit: Qiagen GmbH, D40724 Hilden, Cat. No.
59104; 或者  59104; or
A4. 用 Methylation-God试剂盒: ZYMO Research中国, Cat. No. D5005 或 D5006。  A4. Use the Methylation-God kit: ZYMO Research China, Cat. No. D5005 or D5006.
实施例 3 Example 3
1-5. 同实施例 1步骤 1-5  1-5. Same as Embodiment 1 Step 1-5
6. Ncol酶切法分析 PCR扩增产物中第 141和 142位胞嘧啶位点(包括 C/H/M) 的存在情况(图 4);  6. Ncol digestion analysis of the presence of cytosine positions (including C/H/M) at positions 141 and 142 in the PCR amplification product (Fig. 4);
7.结果见: 所有 C-PCR2A 和 C-PCR2B 分子均没有了酶切点 (5'-C||CTAGG-3'), 不能被酶切, 仍然为 393bp 的完整 DNA分子; 所有 7. Results: All C-PCR2A and C-PCR2B molecules have no cleavage point (5'-C||CTAGG-3'), can not be digested, and are still 393 bp intact DNA molecules;
M-PCR2A和 M-PCR2B分子均保留了该酶切点,被该酶完全酶切成 251bp和 142bp两个片段;所有 H-PCR2A没有该酶切点,不能被酶切;部分 H-PCR2B 保留了该酶切点, 被该酶酶切; Both M-PCR2A and M-PCR2B molecules retained the cleavage point of the enzyme, and were completely digested into two fragments of 251 bp and 142 bp by the enzyme; all H-PCR2A did not have the enzyme cleavage point and could not be digested; part of H-PCR2B retained The enzyme cleavage site is digested by the enzyme;
8. 结果判断: 2种修饰方法的扩增产物均被完全酶切者为该酶切位点胞嘧啶 已经甲基化; 2种修饰方法的扩增产物未被酶切者为该酶切位点胞嘧啶未甲 基化;修饰方法 A的扩增产物未被酶切,而修饰方法 B的扩增产物被酶切者 或者修饰方法 A的扩增产物被酶切,而修饰方法 B的扩增产物未被酶切者为 该酶切位点胞嘧啶己经羟甲基化。  8. Judgment of results: The amplification products of the two modification methods were completely digested, and the cytosine of the two cleavage sites was methylated; the amplification products of the two modification methods were not digested by the enzyme. The cytosine is not methylated; the amplification product of the modification method A is not digested, and the amplification product of the modification method B is digested by the enzyme digestor or the amplification product of the modification method A, and the modification method B is expanded. If the product is not cleaved, the cytosine has been methylolated.
用下列方法之一代替步骤 3中的 A方法, 结果同步骤 8。  Replace the method A in step 3 with one of the following methods, and the result is the same as step 8.
A2. 向 DNA样品溶液中加入终浓度 9 mol/L的亚硫酸氢钠, 70。C水浴 A2. Add a final concentration of 9 mol/L sodium bisulfite to the DNA sample solution, 70. C water bath
1小时, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者 1 hour, purification of the modified DNA, ethanol precipitation, dissolution; or
A3.用 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No.  A3. Using EpiTect Bisulfite Kit: Qiagen GmbH, D40724 Hilden, Cat. No.
59104; 或者  59104; or
A4. 用 Methylation-God试剂盒: ZYMO Research中国, Cat. No. D5005 或 D5006。  A4. Use the Methylation-God kit: ZYMO Research China, Cat. No. D5005 or D5006.

Claims

权利 要求 Rights request
1. 一种 DNA分子中 5-羟甲基胞嘧啶的化学修饰方法,该方法包括下列步 骤: 用亚硫酸氢钠化学修饰法对该 DNA进行处理, 使 DNA中存在的 5-羟甲基胞嘧啶发生转化,转化产物作为 PCR扩增模板,在 PCR中被 扩增为胸腺嘧啶 T或尿嘧啶 U。  A method for chemically modifying 5-hydroxymethylcytosine in a DNA molecule, the method comprising the steps of: treating the DNA with a sodium bisulfite chemical modification method to cause a 5-hydroxymethyl group present in the DNA The pyrimidine is transformed and the transformed product is used as a PCR amplification template and amplified into thymine T or uracil U in PCR.
2. 如权利要求 1所述的 DNA分子中 5-羟甲基胞嘧啶的化学修饰方法,其 中所述用亚硫酸氢钠化学修饰法对该 DNA进行处理是如下之一所列 的方法:  The method for chemically modifying 5-hydroxymethylcytosine in a DNA molecule according to claim 1, wherein the treatment of the DNA by a chemical modification method of sodium hydrogen sulfite is one of the following methods:
A1. 向 DNA样品溶液中加入氢氧化钠水溶液, 95°C水浴 5分钟, 加入终 浓度 5mol/L的亚硫酸氢钠,然后 95°C、 5分钟, 60。C、 25分钟, 95°C、 5分, 60。C、 85分钟, 95° (:、 5分钟, 60。 (、 175分钟, 热循环处理 DNA, 加终浓度 0.3mol/L氢氧化钠终止磺酸化反应和脱硫, 纯化修 饰后的 DNA, 乙醇沉淀, 溶解; 或者  A1. Aqueous sodium hydroxide solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L of sodium hydrogen sulfite, followed by 95 ° C, 5 minutes, 60 ° C. C, 25 minutes, 95 ° C, 5 points, 60. C, 85 minutes, 95° (:, 5 minutes, 60. (, 175 minutes, heat cycle DNA treatment, final concentration of 0.3mol/L sodium hydroxide to terminate the sulfonation reaction and desulfurization, purification of modified DNA, ethanol precipitation , dissolved; or
A2. 向 DNA样品溶液中加入终浓度 9 mol/L的亚硫酸氢钠, 70°C水浴 1 小时, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者  A2. Add a final concentration of 9 mol/L sodium bisulfite to the DNA sample solution, and heat the modified DNA for 1 hour at 70 ° C to precipitate and dissolve the ethanol; or
A3. 用 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No.  A3. Using EpiTect Bisulfite Kit: Qiagen GmbH, D40724 Hilden, Cat. No.
59104; 或者  59104; or
A4.用 Methylation-God试剂盒: ZYMO Research中国, Cat. No. D5005或 D5006。  A4. Use Methylation-God kit: ZYMO Research China, Cat. No. D5005 or D5006.
3. 一种检测 DNA分子中存在的 5-羟甲基胞嘧啶位点的方法,该方法包括 以下步骤:  3. A method of detecting a 5-hydroxymethylcytosine site present in a DNA molecule, the method comprising the steps of:
A.用亚硫酸氢钠化学修饰法对一份 DNA进行处理, 使 DNA中存在 的羟甲基胞嘧啶发生转化, 该转化产物作为 PCR扩增模板, 在 PCR 中被扩增为胸腺嘧啶 T或尿嘧啶 U;  A. A piece of DNA is treated with sodium bisulfite chemical modification method to convert the hydroxymethylcytosine present in the DNA, and the transformed product is used as a PCR amplification template to be amplified into thymine T in PCR. Uracil U;
B.用亚硫酸氢钠化学修饰法对另一份相同的 DNA进行处理,使 DNA 中存在的 5-羟甲基胞嘧啶不发生转化, 在 PCR中被扩增为胞嘧啶 C; B. The same DNA is treated with sodium bisulfite chemical modification method, so that the 5-hydroxymethylcytosine present in the DNA is not transformed, and is amplified into cytosine C in PCR;
C.以所述两份经过处理的 DNA为模板, 用序列特异性引物分别扩增 所述 DNA分子; C. using the two treated DNAs as a template, and sequentially amplifying the DNA molecules with sequence-specific primers;
D.对扩增后的两份 DNA分别测序,比对测序后 DNA中的 C/T或 C U 差别位点, 该 C/T或 C U差别位点即是 DNA分子中存在的 5-羟甲基 胞嘧啶位点。  D. Sequencing the amplified two DNAs separately, comparing the C/T or CU difference sites in the DNA after sequencing, the C/T or CU difference site is the 5-hydroxymethyl group present in the DNA molecule. Cytosine site.
4. 如权利要求 3所述的检测 DNA分子中存在的 5-羟甲基胞嘧啶位点的方 法, 其特征在于: 步骤 D是用限制性内切酶酶切扩增后的两份 DNA, 如果步骤 A扩增后的 DNA产物未被酶切,而步骤 B扩增后的 DNA产 物被酶切或者步骤 A扩增后的 DNA产物被酶切, 而步骤 B扩增后的 DNA产物未被酶切, 则 DNA分子中酶切识别位点上存在 5-羟甲基胞 嘧啶位点。 4. The method for detecting a 5-hydroxymethylcytosine site present in a DNA molecule according to claim 3, wherein: step D is digesting the amplified two DNAs with a restriction enzyme, If the DNA product amplified in step A is not digested, and the DNA product amplified in step B is digested or the DNA product amplified in step A is cleaved, and step B is amplified. The DNA product is not digested, and a 5-hydroxymethylcytosine site is present on the restriction endonuclease recognition site in the DNA molecule.
5. 如权利要求 3或 4所述的检测 DNA分子中存在的 5-羟甲基胞嘧啶位点 的方法, 其中步骤 A中用亚硫酸氢钠化学修饰法对该 DNA进行处理 是如下之一所列的方法:  The method for detecting a 5-hydroxymethylcytosine site present in a DNA molecule according to claim 3 or 4, wherein the step of treating the DNA with sodium hydrogen sulfite chemical modification method in step A is as follows The methods listed:
A1. 向 DNA样品溶液中加入氢氧化钠水溶液, 95°C水浴 5分钟, 加入终 浓度 5mol/L的亚硫酸氢钠,然后 95°C、 5分钟, 60°C、 25分钟, 95° (、 5分, 60°C、 85分钟, 95° (、 5分钟, 60。 (、 175分钟, 热循环处理 DNA, 加终浓度 0.3 mol/L氢氧化钠终止磺酸化反应和脱硫, 纯化修 饰后的 DNA, 乙醇沉淀, 溶解; 或者  A1. Add a sodium hydroxide aqueous solution to the DNA sample solution, water bath at 95 ° C for 5 minutes, add 5 mol / L of sodium bisulfite, then 95 ° C, 5 minutes, 60 ° C, 25 minutes, 95 ° ( , 5 minutes, 60 ° C, 85 minutes, 95 ° (, 5 minutes, 60. (, 175 minutes, heat cycle treatment of DNA, adding a final concentration of 0.3 mol / L sodium hydroxide to terminate the sulfonation reaction and desulfurization, after purification and modification DNA, ethanol precipitation, dissolution; or
A2. 向 DNA样品溶液中加入终浓度 9 mol/L的亚硫酸氢钠, 70°C水浴 1 小时, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者 A2. Add a final concentration of 9 mol/L sodium bisulfite to the DNA sample solution, and heat the modified DNA for 1 hour at 70 ° C to precipitate and dissolve the ethanol; or
A3.用 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No. A3. Using EpiTect Bisulfite Kit: Qiagen GmbH, D40724 Hilden, Cat. No.
59104; 或者  59104; or
A4.用 Methylation-God试剂盒: ZYMO Research中国, Cat. No. D5005或  A4. Use Methylation-God Kit: ZYMO Research China, Cat. No. D5005 or
6. 如权利要求 3或 4所述的检测 DNA中存在的 5-羟甲基胞嘧啶位点的方 法, 其特征在于: 步骤 B中用亚硫酸氢钠化学修饰法对该 DNA进行 处理是: 向 DNA样品溶液中加入氢氧化钠水溶液, 95°C水浴 5分钟, 加入终浓度 5mol/L的亚硫酸氢钠, 55。C水浴 16小时, 加终浓度 0.3 mol/L氢氧化钠终止磺酸化反应和脱硫, 纯化修饰后的 DNA, 乙醇沉 淀, 溶解。 6. The method for detecting a 5-hydroxymethylcytosine site present in DNA according to claim 3 or 4, wherein: the step B is treated with sodium bisulfite chemical modification method to: An aqueous sodium hydroxide solution was added to the DNA sample solution, and a water bath at 95 ° C for 5 minutes was added to a final concentration of 5 mol/L of sodium hydrogen sulfite, 55. After 16 hours of C water bath, the sulfonation reaction and desulfurization were terminated by adding a final concentration of 0.3 mol/L sodium hydroxide, and the modified DNA was purified, precipitated by ethanol, and dissolved.
7. 一种检测 DNA分子中存在 5-羟甲基胞嘧啶的方法,该方法包括以下步 骤 ··  7. A method for detecting the presence of 5-hydroxymethylcytosine in a DNA molecule, the method comprising the steps of:
A. 用亚硫酸氢钠化学修饰法对一份 DNA进行处理, 使 DNA中存在 的羟甲基胞嘧啶发生转化, 该转化产物作为 PCR扩增模板, 在 PCR 中被扩增为胸腺嘧啶 T或尿嘧啶 U;  A. A piece of DNA is treated with sodium bisulfite chemical modification method to convert the hydroxymethylcytosine present in the DNA, and the transformed product is used as a template for PCR amplification and amplified into thymine T in PCR. Uracil U;
B. 用亚硫酸氢钠化学修饰法对另一份相同的 DNA进行处理,使 DNA 中存在的 5-羟甲基胞嘧啶不发生转化, 在 PCR中被扩增为胞嘧啶 C; B. The same DNA is treated with sodium bisulfite chemical modification method, so that the 5-hydroxymethylcytosine present in the DNA is not transformed, and is amplified into cytosine C in PCR;
C.以所述两份经过处理的 DNA为模板, 用序列特异性引物分别扩增 所述 DNA分子, 得到 PCR产物; C. using the two treated DNAs as a template, and respectively amplifying the DNA molecules with sequence-specific primers to obtain a PCR product;
D. 用变性高效液相色谱工作站软件预测 DNA分子变性温度, 在该温 度条件下用变性高效液相色谱对 PCR产物进行突变模式分析;  D. Using denatured high performance liquid chromatography workstation software to predict the DNA molecular denaturation temperature, and then use the denaturing high performance liquid chromatography to analyze the mutation pattern of the PCR product;
E. 步骤 A所处理的 DNA经过 PCR扩增后 PCR产物表现为单链 DNA 色谱峰, 并且步骤 B所处理的 DNA经过 PCR扩增后 PCR产物表现 为双链 DNA色谱峰, 则确定该 DNA分子存在 5-羟甲基胞嘧啶。 E. After PCR amplification of the DNA treated in step A, the PCR product appears as a single-stranded DNA peak, and the PCR-amplified DNA of the DNA treated in step B is expressed by PCR. As a double-stranded DNA chromatographic peak, it was confirmed that 5-hydroxymethylcytosine was present in the DNA molecule.
8. 如权利要求 7所述的检测 DNA分子中存在的 5-羟甲基胞嘧啶的方法, 其中步骤 A中用亚硫酸氢钠化学修饰法对该 DNA进行处理是如下之一 所列的方法: .  8. The method for detecting 5-hydroxymethylcytosine present in a DNA molecule according to claim 7, wherein the step of treating the DNA with sodium hydrogen sulfite chemical modification in step A is one of the following methods : .
A1. 向 DNA样品溶液中加入氢氧化钠水溶液, 95°C水浴 5分钟, 加 入终浓度 5mol/L 的亚硫酸氢钠, 然后 95°C、 5 分钟, 60°C、 25 分钟, 95°C、 5分, 60。C、 85分钟, 95°C、 5分钟, 60°C 175分 钟, 热循环处理 DNA,加终浓度 0.3 mol/L氢氧化钠终止磺酸化反 应和脱硫, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者  A1. Add sodium hydroxide solution to the DNA sample solution, water bath at 95 ° C for 5 minutes, add 5 mol / L sodium bisulfite, then 95 ° C, 5 min, 60 ° C, 25 min, 95 ° C , 5 points, 60. C, 85 minutes, 95 ° C, 5 minutes, 60 ° C 175 minutes, heat cycle DNA treatment, add a final concentration of 0.3 mol / L sodium hydroxide to terminate the sulfonation reaction and desulfurization, purification of the modified DNA, ethanol precipitation, dissolution ; or
A2.向 DNA样品溶液中加入终浓度 9 mol/L的亚硫酸氢钠, 70°C水浴 A2. Add a final concentration of 9 mol/L sodium bisulfite to the DNA sample solution, 70 ° C water bath
1小时, 纯化修饰后的 DNA, 乙醇沉淀, 溶解; 或者 1 hour, purification of the modified DNA, ethanol precipitation, dissolution; or
A3.用 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No.  A3. Using EpiTect Bisulfite Kit: Qiagen GmbH, D40724 Hilden, Cat. No.
59104; 或者  59104; or
A4.用 Methylation-God试剂盒: ZYMO Research中国, Cat. No. D5005 或 D5006。  A4. Use Methylation-God kit: ZYMO Research China, Cat. No. D5005 or D5006.
9. 如权利要求 7或 8所述的检测 DNA中存在的 5-羟甲基胞嘧啶的方法, 其特征在于:步骤 B中用亚硫酸氢钠化学修饰法对该 DNA进行处理是: 向 DNA样品溶液中加入氢氧化钠水溶液, 95°C水浴 5分钟,加入终浓 度 5 mol/L的亚硫酸氢钠, 55°C水浴 16小时,加终浓度 0.3 mol/L氢氧 化钠终止磺酸化反应和脱硫, 纯化修饰后的 DNA, 乙醇沉淀, 溶解。 The method for detecting 5-hydroxymethylcytosine present in DNA according to claim 7 or 8, wherein the DNA is treated with sodium hydrogen sulfite chemical modification method in step B: Add sodium hydroxide aqueous solution to the sample solution, water bath at 95 ° C for 5 minutes, add 5 mol / L sodium hydrogen sulfite, the water bath at 55 ° C for 16 hours, and add the final concentration of 0.3 mol / L sodium hydroxide to terminate the sulfonation reaction. And desulfurization, purification of the modified DNA, ethanol precipitation, and dissolution.
10. 亚硫酸氢钠用于修饰或检测 DNA分子中存在的 5-羟甲基胞嘧啶的用 途。 10. Sodium bisulfite is used to modify or detect the use of 5-hydroxymethylcytosine present in DNA molecules.
11.如权利要求 8所述的用途, 其特征在于: 所述亚硫酸氢钠修饰使 DNA 分子中存在的 5-羟甲基化胞嘧啶发生转化, 转化产物作为 PCR扩增模 板, 在 PCR中被扩增为胸腺嘧啶 T或尿嘧啶 U。  The use according to claim 8, wherein: the sodium hydrogen sulfite modification converts 5-hydroxymethylated cytosine present in the DNA molecule, and the transformed product is used as a PCR amplification template in PCR. Amplified to thymine T or uracil U.
12.如权利要求 10或 11所述的用途, 其特征在于: 所述的亚硫酸氢钠是 含有亚硫酸氢钠的 EpiTect Bisulfite试剂盒: Qiagen GmbH, D40724 Hilden, Cat. No. 59104或者 Methylation-God试剂盒: ZYMO Research 中国, Cat. No. D5005或 D5006。  The use according to claim 10 or 11, wherein the sodium hydrogen sulfite is an EpiTect Bisulfite kit containing sodium hydrogen sulfite: Qiagen GmbH, D40724 Hilden, Cat. No. 59104 or Methylation- God kit: ZYMO Research China, Cat. No. D5005 or D5006.
PCT/CN2010/001107 2010-07-22 2010-07-22 Chemical modification method and detection method of 5-hydroxymethylcytosine in dna molecules WO2012009828A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2010/001107 WO2012009828A1 (en) 2010-07-22 2010-07-22 Chemical modification method and detection method of 5-hydroxymethylcytosine in dna molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2010/001107 WO2012009828A1 (en) 2010-07-22 2010-07-22 Chemical modification method and detection method of 5-hydroxymethylcytosine in dna molecules

Publications (1)

Publication Number Publication Date
WO2012009828A1 true WO2012009828A1 (en) 2012-01-26

Family

ID=45496424

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/001107 WO2012009828A1 (en) 2010-07-22 2010-07-22 Chemical modification method and detection method of 5-hydroxymethylcytosine in dna molecules

Country Status (1)

Country Link
WO (1) WO2012009828A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1346054A (en) * 2000-09-29 2002-04-24 北京市肿瘤防治研究所 Method for quickly detecting CpG cytosine methylation
WO2010037001A2 (en) * 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1346054A (en) * 2000-09-29 2002-04-24 北京市肿瘤防治研究所 Method for quickly detecting CpG cytosine methylation
WO2010037001A2 (en) * 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SEUNG-GI JIN ET AL.: "Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine, art. e1", NUCLEIC ACIDS RESEARCH, vol. 38, no. 11, 5 April 2010 (2010-04-05), pages 1 - 7 *
YUN HUANG ET AL.: "The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing, art e88", PLOS ONE, vol. 5, no. 1, 26 January 2010 (2010-01-26), pages 1 - 9 *

Similar Documents

Publication Publication Date Title
US8911937B2 (en) Method for detecting methylation status by using methylation-independent primers
EP2906715B1 (en) Compositions, methods, systems and kits for target nucleic acid enrichment
WO2017039002A1 (en) Oxidizing agent for 5-hydroxymethylcytosine and method for analyzing 5-hydroxymethylcytosine
US20120149593A1 (en) Methods and arrays for profiling dna methylation
CA2555704A1 (en) Method for detection of promoter methylation status
WO2014205981A1 (en) High-throughput sequencing detection method for methylated cpg islands
JP2005514035A (en) Method for detecting cytosine-methylation pattern by exponential ligation of hybridized probe oligonucleotide (MLA)
WO2010039991A2 (en) Method of generating informative dna templates for high-throughput sequencing applications
US20070059753A1 (en) Detecting gene methylation
EP4083231A1 (en) Compositions and methods for nucleic acid analysis
WO2011057354A1 (en) Epigenetic analysis
CA2901120C (en) Methods and kits for identifying and adjusting for bias in sequencing of polynucleotide samples
JP4528475B2 (en) Method for identifying 5-position methylated modified product
WO2007101075A2 (en) Double-ligation method for haplotype and large-scale polymorphism detection
WO2012083845A1 (en) Methods for removal of vector fragments in sequencing library and uses thereof
CN114134205B (en) Deaminase mediated N in DNA 4 Single base resolution localization analysis method of methyl cytosine
US20150299809A1 (en) Biomarkers for Clinical Cancer Management
WO2012009828A1 (en) Chemical modification method and detection method of 5-hydroxymethylcytosine in dna molecules
US20090075251A1 (en) Method for analysis of cytosine methylation
US20040248120A1 (en) Detection of specific dinucleotides in dna-samples by fluorescence resonance energy transfer (fret)
WO2013173475A2 (en) Primers for analyzing methylated sequences and methods of use thereof
CA2513159A1 (en) Method for the detection of cytosine methylation patterns with high sensitivity
JP2010035533A (en) Detection method of methylated cytosine
US20090215057A1 (en) Analysis molecule and method for the analysis of a nucleotide position in a nucleic acid
US20100120036A1 (en) Method for amplifying dna fragment

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10854859

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10854859

Country of ref document: EP

Kind code of ref document: A1